MabThera 1400 mg Solution for Subcutaneous Injection

Vaccines

MabThera 1400 mg Solution for Subcutaneous Injection

Brand: Roche Products Limited

₦394,800In stock
MabThera 1400 mg Solution for Subcutaneous Injection contains rituximab, a monoclonal antibody medicine used in the treatment of certain cancers and immune-related conditions. It works by targeting specific proteins on certain immune cells, helping to control abnormal cell growth and immune responses. MabThera is administered through subcutaneous injection and is typically prescribed as part of a treatment plan supervised by a specialist or qualified healthcare professional. Medicines in this category are commonly used in carefully monitored treatment programs. The product is supplied as a single-dose solution for subcutaneous injection, intended for administration according to the dosage and schedule recommended by a healthcare professional. MabThera 1400 mg Solution for Subcutaneous Injection is classified as a prescription-only medicine (POM) and should be used strictly under medical supervision. Important Notice MabThera should only be administered by trained healthcare professionals in appropriate clinical settings. Patients receiving this medicine should follow their doctor’s recommendations and attend scheduled monitoring appointments as part of their treatment plan. Order MabThera 1400 mg Solution for Subcutaneous Injection Online MabThera 1400 mg Solution for Subcutaneous Injection may be available through licensed online pharmacies and medical supply providers. Always ensure medicines are NAFDAC-approved and sourced from reputable providers to guarantee safety, authenticity, and quality.

Dosage

<p>Before beginning or administering this medication, always get advice from your pharmacist or doctor.</p>

Directions for use

<p>Before beginning or administering this medication, always get advice from your pharmacist or doctor.</p>